Trial Profile
A Phase I, Randomized, Single-Blind, Placebo-Controlled Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Ascending Oral Doses Of AZD9567 In Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Mizacorat (Primary) ; Prednisolone
- Indications Respiratory tract disorders; Rheumatoid arthritis
- Focus Adverse reactions; First in man; Pharmacokinetics
- Sponsors AstraZeneca
- 29 Sep 2016 Status changed from active, no longer recruiting to completed.
- 07 Sep 2016 Planned End Date changed from 1 Oct 2016 to 1 Sep 2016.
- 07 Sep 2016 Status changed from recruiting to active, no longer recruiting.